Top

News & Events

Client News

Client News Our News Insights Features

22 December 2016
Licence agreement for Composite Human Antibody™ technology

21 December 2016
New Data Shows that MammaPrint® Substantially Impacts how Breast Cancer Patients in Germany are Treated

20 December 2016
Portfolio company PsiOxus Therapeutics signs exclusive worldwide licence agreement with BMS for NG-348 its first “armed” oncolytic virus

20 December 2016
Recce reports encouraging anti-viral activity for lead compound RECCE® 327

19 December 2016
AmpliPhi Biosciences Reports Favorable Final Results From Phase 1 Trial of AB-SA01 in Chronic Rhinosinusitis Patients

15 December 2016
Three New Studies Presented at San Antonio Breast Cancer Symposium Further Demonstrate Value of MammaPrint® and BluePrint® in Individualizing Treatment for Breast Cancer Patients

15 December 2016
Clinigen signs Global Access agreement for BioQ Pharma’s post-operative pain management product, Ropivacaine Readyfusor

14 December 2016
Nanobiotix reports positive Phase I/II preliminary data on feasibility and safety of NBTXR3 in liver cancers trial

14 December 2016
Dimerix Receptor-HIT data presented by Takeda at British Pharmacological Society Annual meeting

08 December 2016
Higher M&A Activity and Investor Cash Expected to Re-invigorate Pharma and Biotech in 2017

08 December 2016
Adherium’s Smartinhaler™ technology chosen for major asthma initiative

07 December 2016
Polyganics announces Birmingham Hand Centre efficacy study of nerve conduit NEUROLAC® in finger surgery

06 December 2016
Dimerix Completes Recruitment of Part A of its Phase 2 Trial of DMX-200 in Chronic Kidney Disease

05 December 2016
AmpliPhi Biosciences Reports Favorable Final Results From Phase 1 Trial of AB-SA01

05 December 2016
Puridify and GSK extend evaluation of FibroSelect purification technology

02 December 2016
Agendia’s MammaPrint® and BluePrint® Tests Highlighted in Multiple Presentations at the 2016 San Antonio Breast Cancer Symposium, Adding Further Clinical Utility

02 December 2016
DNAe Congratulates Executive Chairman Professor Chris Toumazou on Elektra European Electronics Industry Lifetime Achievement Award

01 December 2016
Halaven® (eribulin) receives registration in South Africa for treatment of women with advanced breast cancer

30 November 2016
Half year results: Integrated service offering driving revenue growth

29 November 2016
Presentations at French Society of Plastic, Reconstructive and Aesthetic Surgery Reinforce Benefits of ReCell®

29 November 2016
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3

28 November 2016
Imperial Innovations: Portfolio company TopiVert receives IND approval for TOP1630 in the treatment of dry eye syndrome

17 November 2016
AmpliPhi Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

17 November 2016
Management Team Strengthened as Auspherix Drives New Class of Antibacterials Towards the Clinic

17 November 2016
Independent clinical study shows Adherium’s Smartinhaler™ dramatically improves clinical outcomes and medication adherence in children with asthma

15 November 2016
Nanobiotix revenue for Q3 2016

15 November 2016
AdAlta Extends Board with Appointment of US-Based Non Executive Director

14 November 2016
AmpliPhi Biosciences Announces Settlement of Pending Lawsuit

14 November 2016
Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection

14 November 2016
Nanobiotix Presents NBTXR3 Preclinical Data Demonstrating its Potential Usage as In Situ Vaccine for Cancer at The Society for Immunotherapy of Cancer Annual Meeting

11 November 2016
AmpliPhi Biosciences Reports Third Quarter 2016 Financial Results and Provides Corporate Update

10 November 2016
Cell Medica and Baylor College of Medicine expand partnership to develop off-the-shelf CAR-NKT cells for cancer treatment

09 November 2016
Innovative Regenerative Approach to Healing Diabetic Foot Ulcers Now Being Trialed at Two Additional UK sites

09 November 2016
DNAe to Present New Data on G-BSI Blood-to-Result Test for Rapid Identification of Bloodstream Infections at AMP 2016

08 November 2016
Agendia’s proven breast cancer recurrence assay, MammaPrint, now available in the Middle East

08 November 2016
Evaluate Ltd Receives Significant Investment from HgCapital to Expand Products and Services

08 November 2016
NG Biotech To Unveil Next Generation Integrated hCG Rapid Diagnostic Blood Test, Developed In Conjunction With Atomo Diagnostics

08 November 2016
AdAlta licenses Alzheimer’s disease-specific shark antibodies to Crossbeta Biosciences for therapeutic and diagnostic development

07 November 2016
Appointment of Chief Executive Officer

07 November 2016
AdAlta and XL-protein announce collaboration to develop a long acting version of its lead fibrosis drug candidate AD-114 using PASylation® Technology

07 November 2016
Mucosis Initiates First-in-Human Study of SynGEM®, a Needle-Free Nasal Spray RSV Vaccine

02 November 2016
GE Healthcare and Valneva Collaboration Delivers Optimized Cell Culture Medium for Vaccine Production

01 November 2016
Agendia Announces the Award of a New Category 1 CPT Code from the American Medical Association for the MammaPrint® 70-Gene Breast Cancer Recurrence Assay

01 November 2016
AmpliPhi Biosciences Granted Small and Medium Enterprise Status by European Medicines Agency

01 November 2016
GE Healthcare enhances single-use manufacturing capabilities with facility expansion and automation

27 October 2016
Atomo Diagnostics Receives Grant to Develop New, Innovative HIV Self-Test Solution

27 October 2016
Agendia Expands its Business Activities in Germany

25 October 2016
AmpliPhi Biosciences Announces Favorable Topline Safety and Tolerability Results from Its Phase 1 Trial in Patients with Chronic Rhinosinusitis

25 October 2016
Seventure Partners to Lead Microbiome Session at Bio-Europe 2016

25 October 2016
Clinigen and BTG extend global partnership with new exclusive Global Access agreement

24 October 2016
Abzena makes two senior executive appointments to drive growth of international business

24 October 2016
Imperial Innovations: Portfolio company Veryan Medical announces the completion of subject enrolment into the MIMICS-2 clinical study

20 October 2016
Adherium Announces Key Technology Patent Granted in US

20 October 2016
Avita Medical’s ReCell® devices now treating burns in South Africa and Benelux

20 October 2016
Synaffix Enters into a Commercial License Agreement with ADC Therapeutics

19 October 2016
AdAlta to present at forthcoming industry conferences

19 October 2016
U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell® in Life-Threatening Injuries

18 October 2016
Crescendo Biologics Appoints Theodora Harold as Chief Financial Officer

18 October 2016
Clinigen launches Japanese business to strengthen Asian presence

17 October 2016
Agendia Appoints Three Leading Cancer Physicians to Its Medical Advisory Board

17 October 2016
AmpliPhi Biosciences Appoints Dr. Carrie-Lynn Langlais Furr as Vice President of Regulatory Affairs and Program Management

17 October 2016
Hookipa Secures ‎EUR 4.16 million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies

17 October 2016
Bespak Launches Syrina™ AR 2.25 Auto-Injector for Fully-Automatic Delivery of Viscous Drug Formulations

17 October 2016
Worldwide Medtech Sales Forecast to Reach $529.8 Billion by 2022

14 October 2016
Consort Medical closes Syrina™ Auto-Injector Master Development Agreement

14 October 2016
AdAlta update on Orphan Drug Designation application for lead drug targeting idiopathic pulmonary fibrosis

13 October 2016
Imperial Innovations Group plc: Year-end results

11 October 2016
Dr. Torsten Mummenbrauer Appointed SVP Business Development & Licensing of Hookipa Biotech

10 October 2016
Portfolio company Crescendo Biologics signs collaboration and licence agreement with Takeda worth up to $790m

10 October 2016
Crescendo Biologics and Takeda Enter Collaboration for Humabody®-based Therapeutics Worth up to $790m

06 October 2016
Imperial Innovations: First patients dosed in TopiVert’s Phase IIa proof-of-concept study in moderate to severe ulcerative colitis

05 October 2016
Karus Therapeutics Announces First Lymphoma Patients Dosed with KA2237 in Clinical Study at the MD Anderson Cancer Center

04 October 2016
Nanobiotix Strengthens U.S. leadership with appointments of Head of U.S. Clinical Development and Director of Investor Relations

04 October 2016
Interim analysis supports continued development of DMX-200 for the treatment of Chronic Kidney Disease

30 September 2016
Puridify named as finalist for two prestigious bioprocess industry awards

30 September 2016
BARDA Awards $51.9 Million Contract to DNAe to Develop Semiconductor DNA Sequencing Platform for Rapid Diagnosis of Antimicrobial Resistant Infections and Influenza

29 September 2016
Avita Medical Signs Exclusive Distributor Deal in Iran

29 September 2016
GE Healthcare opens USD 7.4 million APAC Fast Trak Bioprocessing Technology and Training Center in South Korea

28 September 2016
Seventure Partners Life Sciences Update for May – September 2016

28 September 2016
Crescendo strengthens IP portfolio with U.S. patent to transgenic mouse platform for generating Humabody® therapeutics

28 September 2016
Shaun Chilton to take over as Chief Executive Officer

28 September 2016
Transformational Year Delivers 25% Growth in Adjusted EPS*

27 September 2016
Xellia Pharmaceuticals Expands Croatian Anti-Infective Product and Innovation Capabilities to Tackle Antimicrobial Resistance Crisis

26 September 2016
Clinigen Group and Cumberland Pharmaceuticals launch Ethyol® in the U.S.

23 September 2016
Avita Medical to Hold ReCell® Symposium at Leading European Burns Association Course

22 September 2016
R-Pharm produces biological drugs in Yaroslavl with GE Healthcare's FlexFactory™ manufacturing platform

21 September 2016
Forbion’s portfolio company Akarna Therapeutics Ltd

21 September 2016
AmpliPhi Biosciences Provides Update on Phase 1 Trial in Chronic Rhinosinusitis Patients

21 September 2016
Innovations invests £5.1m in Artios Pharma Limited

20 September 2016
Re-focused, science based and commercially driven with £19.9m of cash

19 September 2016
Announcement from Bespak

19 September 2016
Bpifrance grants Nanobiotix a €2M interest-free loan to support final development stage of lead product, NBTXR3

16 September 2016
AdAlta to present at two new drug therapy conferences next week

14 September 2016
Worldwide Prescription Drug Sales Forecast to Grow 6.3% Annually

13 September 2016
AmpliPhi Biosciences Announces Topline Results from Its Phase 1 Phage Therapy Trial Conducted in the United States

13 September 2016
AmpliPhi Biosciences to Participate in Upcoming Conferences

13 September 2016
Directorate change

13 September 2016
Abzena: AGM business update

12 September 2016
AdAlta signs agreement with FujiFilm Diosynth Biotechnologies to begin manufacturing its lead fibrosis drug candidate

12 September 2016
AmpliPhi Biosciences’ Bacteriophage Cocktail Shown to Prevent C. difficile Biofilm Formation and Reduce Colonization

07 September 2016
Recent announcement from Bespak

02 September 2016
Avita Medical’s Regenerative Skin Technology significantly reduces burn scars and healing time

01 September 2016
Adherium expands its international presence with Mr Thomas Lynch as Chairman & Dr Doug Wilson as Medical Director

01 September 2016
Nanobiotix half year results for the six months ended 30 June 2016

31 August 2016
AdAlta Receives Australian Government Grant to Advance Understanding of Potential New Lung Fibrosis Therapy

24 August 2016
Cell Medica collaborates with UCL to develop modified T cell receptor products for cancer treatment

24 August 2016
Cell Medica and UCL collaborate to develop modified T cell receptor products for the treatment of cancer

23 August 2016
GE Healthcare expands cell therapy portfolio with license of STEMCELL Technologies’ T-Cell reagents

22 August 2016
AdAlta IPO to Accelerate New Therapy for Lung Fibrosis

17 August 2016
GE Healthcare and Sealed Air enter an exclusive agreement to deliver film for single-use bioprocess systems

17 August 2016
Pharma and Medtech Sectors Struggle in First Half of 2016

16 August 2016
AmpliPhi Biosciences Reports Second Quarter 2016 Financial Results and Provides Corporate Update

12 August 2016
Drug Discovery Company AdAlta Raises AUD$10m in Over-Subscribed Australian IPO to Accelerate New Therapies for Lung Fibrosis

10 August 2016
AmpliPhi Biosciences Confirms Clinical Trial Progress and Announces Upcoming Conference Call to Provide Corporate Update and Discuss Second Quarter 2016 Financial Results on August 15, 2016

04 August 2016
AmpliPhi Biosciences Granted Japanese Patent Covering the Use of Phage Therapy to Resensitize Pseudomonas aeruginosa Infections to Antibiotics

03 August 2016
AmpliPhi Biosciences Completes Enrollment of its Investigational Phage Therapy Trial Targeting Staphylococcus aureus

01 August 2016
Dimerix announces outcomes of DMX-200 pre-IND meeting with the FDA

01 August 2016
Autifony Therapeutics successfully completes Phase I study of AUT00206, a first-in-class Kv3 modulator for schizophrenia

01 August 2016
Trod Medical Receives a New Patent Allowance for Prostate Focal Therapy Encage Device

28 July 2016
Dimerix Announces Pre-clinical Program, DMX-250, Targeting Heterodimers active in NASH, a major Liver Disease

25 July 2016
Faron enters into an agreement with Abzena for the manufacture of Clevegen®

21 July 2016
GE Healthcare - Achieve shorter run times with Superdex™ 75 Increase size exclusion chromatography columns

20 July 2016
Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine

20 July 2016
Cell Medica - Lead cancer immunotherapy candidate granted EU orphan drug designations

20 July 2016
Clinigen Group - Year end trading update

14 July 2016
Abzena and Baylor Scott & White Research Institute team up to form Denceptor Therapeutics to develop novel immunotherapies

13 July 2016
Nanobiotix revenue for Q2 2016

12 July 2016
Cell Medica acquires Delenex Therapeutics

12 July 2016
Cell Medica acquires Delenex Therapeutics AG to expand T Cell immunotherapy programme

11 July 2016
Avita Medical announces Rights Issue raises AU$9 million

08 July 2016
Australian Drug Discovery Company AdAlta, Announces IPO to Accelerate New Therapies for Lung Fibrosis

06 July 2016
GHO Capital & Ardian team with Envision leadership to acquire the Envision Pharma Group from the Halifax Group

06 July 2016
Econic raises £5m to develop novel catalyst technology

05 July 2016
BioGeneration Ventures announces first close of its third fund

04 July 2016
Multiplex immunoassays with Firefly® particle technology

04 July 2016
Auspherix Appoints Experienced Anti-Infectives Clinician to Scientific Advisory Board

01 July 2016
Avita Medical scoops One Nucleus Summer BioNewsRound Award 2016

30 June 2016
PsiOxus and Bristol-Myers Squibb announce combination study and Immuno-Oncology clinical collaboration

30 June 2016
First-In-Human Study Of Immbio’s Novel Pneumococcal Vaccine Pnubiovax Shows Vaccine To Be Safe And Immunogenic

30 June 2016
LaingBuisson appoints Stephen Dorrell as Chairman

29 June 2016
Clinigen and Horizon Pharma enter partnership to initiate European Managed Access program for RAVICTI® (glycerol phenylbutyrate) Oral Liquid

29 June 2016
Avita Medical Appoints a leading Health Economics Group

28 June 2016
Regenerative Medicine Publishes Key Findings from Avita Medical’s 2016 Skin Regeneration Symposium

28 June 2016
Storm Therapeutics raises £12m to develop novel cancer therapeutics

28 June 2016
Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology Center in China

27 June 2016
Avita Medical Awarded US$7.96m in BARDA Extension Deal

23 June 2016
ImmBio Selected for an Oral Presentation at the 10th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD-10)

21 June 2016
Polyganics Announces CE Mark for NEUROCAP®, the Nerve Capping Device for Treatment and Prevention of Symptomatic Neuroma

20 June 2016
Avita Medical Appoints a COO and a VP of Sales and Marketing

20 June 2016
Circassia cat allergy Phase III study

17 June 2016
Cell Medica and Baylor College of Medicine announce Exclusive Licensing Agreement and Co-development Partnership to create next generation cellular immunotherapy products for the treatment of cancer

17 June 2016
Cell Medica and Baylor College of Medicine partner to create next generation cellular immunotherapy products for cancer treatment

16 June 2016
FCF II Co-Invest I supports EUR 22M Series B of Allecra Therapeutics

16 June 2016
Jörn Aldag Appointed CEO of Hookipa Biotech

16 June 2016
Avita Medical announces non-renounceable rights issue to raise up to approximately AUD$11m

16 June 2016
TROD Medical’s Prostate Focal Therapy Device EncageTM Advances in US and UK Clinical Studies

14 June 2016
Dimerix’s Chief Scientific Advisor Awarded British Pharmacological Society’s Novartis Prize

14 June 2016
Clinigen and Galen enter exclusive Global Access agreement for chemotherapy drug DaunoXome®

14 June 2016
Full year results: revenues up 74%, strong outlook within growing market

13 June 2016
GE Healthcare launches next generation BiacoreTM molecular interaction analysis platform

09 June 2016
NovaBiotics Presents Three New Posters on Anti-Infectives Pipeline at 39th European Cystic Fibrosis Society Conference

09 June 2016
Clinigen announces partnership with Basilea to initiate a Managed Access program for isavuconazole to treat patients with invasive fungal infections in Europe

08 June 2016
PnuVax to acquire inactivated yellow fever vaccine intellectual property from GE Healthcare

07 June 2016
New Data Shows Agendia’s MammaPrint® can Prevent Under and Over Treatment of Breast Cancer Patients with an Intermediate/Indeterminate OncotypeDx Recurrence Score

07 June 2016
Avita Medical signs deal for distribution in Malaysia

07 June 2016
NovaBiotics Highlights Importance of a Co-ordinated Approach to Antimicrobial Resistance

06 June 2016
Health for Life Capital™ Participates in $50m Financing of Microbiome Company Vedanta Biosciences

03 June 2016
Shifting CAR-Ts into a Higher Gear

02 June 2016
AmpliPhi Biosciences to be Granted European Patent Covering the Use of Phage Therapy to Resensitize Bacterial Infections To Antibiotics

01 June 2016
Agendia Appoints Dr. Gabriel Hortobagyi as Chairman to their Medical Advisory Board

01 June 2016
AmpliPhi Biosciences Announces Pricing of Registered Direct Public Offering of Common Stock and Warrants

01 June 2016
Nanobiotix receives US$1m milestone payment from PharmaEngine

31 May 2016
AmpliPhi Biosciences’ CEO to Discuss Novel Approaches to Fighting Drug-Resistant Pathogens in Panel at BIO International

31 May 2016
Clinical Study in UK to Evaluate ReGenerCell™ for Diabetic Foot Ulcer Treatment

31 May 2016
Nanobiotix establishes promising preclinical proof-of-concept in Immuno Oncology

26 May 2016
Indegene and TranScrip launch IntraScience - an innovative regulatory, safety and medical services solution for global bio-pharmaceutical companies

25 May 2016
Xellia Pharmaceuticals Expands Budapest Facilities to Strengthen Anti-infective Product Capabilities

24 May 2016
AmpliPhi Biosciences Announces Start of First Phage Therapy Trial in U.S. Under IND

24 May 2016
Cell Medica Expands Management Team with Experienced Pharmaceutical Executives

19 May 2016
Clinigen expands US presence with opening of new Yardley headquarters

18 May 2016
Synthon Advances Clinical Evaluation of Anti-HER2 ADC SYD985 in an Expanded Cohort of HER2-positive Metastatic Breast Cancer Patients

16 May 2016
Nanobiotix revenue for the 1st quarter of 2016

12 May 2016
Agendia Appoints Dr. M. William Audeh to Chief Medical Officer

10 May 2016
Clinigen Group and Cumberland Pharmaceuticals enter into exclusive U.S. commercialisation agreement for oncology support drug Ethyol®

10 May 2016
JHL Biotech Opens Innovative Biosimilars Manufacturing Facility in China

09 May 2016
Polyganics Announces Enrollment of First Patients in Multicenter Study for NEUROCAP Nerve Capping Device

09 May 2016
Avita’s novel ReNovaCell™ technology offers key advantages in skin repigmentation of burn scars, when combined with medical needling

06 May 2016
Dimerix: Australian Research Council Linkage Grant to Progress Discovery Platform

06 May 2016
Avita Medical: Research Confirms that ReCell® Reduces Long-Term Scarring and Itching Outcomes in Pediatric Burns Treatment

05 May 2016
Seventure Partners Life Sciences Business Update 2016

05 May 2016
Clinigen develops new Foscavir® (foscarnet sodium) product presentation

03 May 2016
Regenerative Medicine Approach delivers healing and cost savings for Chronic Wounds

03 May 2016
Avita Medical’s ReCell® Technology Demonstrated at Vitiligo Conferences in China

29 April 2016
Nanobiotix: 2015 Annual Results

28 April 2016
Dimerix requests US FDA pre IND meeting and converts performance shares

22 April 2016
International Experts to Present on Avita Medical’s Regenerative Medicine Approach at Medical Symposium, London

22 April 2016
International Experts Honoured with Awards at 4th Annual Skin Regeneration Symposium

21 April 2016
ReNovaCell™ Skin Regeneration Technology Improves Pigmentation and Appearance of Scars

20 April 2016
ReGenerCell™ Skin Regeneration Technology Decreases Size and Pain in Chronic Wounds

19 April 2016
Dimerix Receives TGA Special Access Scheme Approval to Continue to Supply Propagermanium to Kidney Patients on its DMX-200 Phase II trial

19 April 2016
Skin Regeneration Technology Critical to Recovery and Quality of Life in Burns Patients Say Top Clinicians

15 April 2016
MINDACT Trial Findings on Agendia’s MammaPrint to be Presented during AACR Annual Meeting 2016

14 April 2016
AmpliPhi Biosciences Terminates Collaboration Agreement with Intrexon

14 April 2016
Dr Richard Butt appointed CEO

13 April 2016
AmpliPhi Biosciences Presents Data Showing Bacteriophage Product Candidate Kills Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients

12 April 2016
Abcam enables faster drug and biomarker discovery with immunoassay research suite

12 April 2016
GE Healthcare expands European capabilities to support accelerated biomanufacturing

12 April 2016
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe

12 April 2016
Forbion closes third life sciences fund, FCF III, raising over $200m

11 April 2016
AdAlta Announces i-body Publication in the Journal of Biological Chemistry

11 April 2016
Seventure Partners Announces Key Appointments to Strengthen its Microbiome and Food-Health Expertise

08 April 2016
AmpliPhi Biosciences Announces Conversion of all Series B Redeemable Preferred Stock into Common Stock

07 April 2016
Imperial Innovations: Strategic relationships developed and additional funds raised

06 April 2016
Abzena and FairJourney Biologics form alliance to provide continuum of antibody services from discovery to manufacture

05 April 2016
Avita Medical Announces 4th Annual Skin Regeneration Symposium

30 March 2016
AmpliPhi Biosciences Reports Full-Year 2015 Financial Results

30 March 2016
Clinigen joins two key European alliances in the fight to protect patients from the threat of counterfeit drugs

30 March 2016
Amal Therapeutics raises CHF 3 million in a Series A financing round led by Boehringer Ingelheim Venture Fund

29 March 2016
GE Healthcare launches collaborative research scheme to support growth of Turkish biopharmaceutical industry

29 March 2016
Mucosis to Present at World Vaccines Congress 2016

24 March 2016
ITM and Scil Proteins Announce New Partnership for Targeted Radio Conjugates

23 March 2016
Adherium Establishes North American Operations and Appoints Senior Vice President of Business Development to Lead Market Expansion

22 March 2016
Strategic prioritisation on discovery platform and commercialisation

17 March 2016
EP Vantage Releases its Annual Analysis of Pharma & Biotech and Medtech Sector Performance: 2015 in Review Reports

17 March 2016
Innovations Portfolio Company TopiVert Reports Successful Phase I Clinical Study for the Treatment of Ulcerative Colitis

15 March 2016
Polyganics appoints Dr Jan Öhrström to Supervisory Board

15 March 2016
Adherium Confirms Clearance to Market in Canada for Flagship Products

15 March 2016
Avita Medical Completes Repigmentation Study Enrollment

11 March 2016
Nanobiotix completes a EUR 21.3 million private placement of new ordinary shares

11 March 2016
Avita Medical signs Distributor Deal with China’s largest healthcare Group

11 March 2016
ADC Therapeutics Doses First Patient in Phase I Trial of ADCT-402 in CD-19 Positive B-cell Non-Hodgkin Lymphomas

09 March 2016
Business update – strong second half momentum

09 March 2016
Avita Medical Announces Positive Results from Randomized, Multicentre EU Study of ReGenerCell™ for Treatment of Chronic Venous Leg Ulcers

08 March 2016
Agendia to Highlight New MammaPrint Data at the 2016 European Breast Cancer Conference as a Prelude to Upcoming MINDACT Trial Findings

08 March 2016
AmpliPhi Biosciences CEO to Present at 28th Annual ROTH Conference

07 March 2016
Avita Medical Announces U.S. FDA Approval for Increase in Compassionate Use of ReCell® Patient Cases

02 March 2016
CONTINUED STRONG GROWTH WITH EPS UP 21%

02 March 2016
Clinigen acquires US-approved Totect® (dexrazoxane) from Biocodex to become the only global source for the treatment of anthracycline extravasation

02 March 2016
Avita Medical Launches Expanded Regenerative Product Range in Europe

01 March 2016
Vortex BioSciences co-founder receives US Presidential award for groundbreaking “Liquid Biopsy” technique

01 March 2016
DySIS Medical Signs Significant Deal with ITEM Medical Technologies to Support National Screening Programme in Turkey

01 March 2016
New Understanding of the Mechanism of Neurodegeneration Leads to a Novel Approach to Treatment for Alzheimer’s Disease

29 February 2016
Wanda™ partners with leading US Hospital Group Dignity Health™ to launch oncology decision support software platform - OncoVerse™

29 February 2016
On Rare Disease Day, Clinigen and CheckOrphan celebrate over 100

26 February 2016
Nanobiotix 2015 Q4 and annual revenues

25 February 2016
Ablynx Announces 2015 Full Year Results

22 February 2016
Innovations leads £13.5m funding round in Precision Ocular Ltd

19 February 2016
Dimerix receives US Patent allowance for chronic kidney disease drug candidate

17 February 2016
NetScientific appoints Professor Stephen Smith as Non-Executive Director

16 February 2016
Forbion invests in Akarna Therapeutics $15 Million Series B Financing to Develop Novel FXR Agonist-Based Therapies for the Treatment of NASH and other Fibrotic Diseases

11 February 2016
Avita Medical Appoints Distributor for Germany, Switzerland, Austria

11 February 2016
New England Journal of Medicine Publishes Ablynx’s Phase II TITAN Study

09 February 2016
AmpliPhi Biosciences Announces Award of Federal Research Grant from Australia to its Collaboration Partner, Westmead Institute

09 February 2016
PDS Biotechnology partners with National Cancer Institute in Phase II clinical trials for novel cancer immunotherapies

09 February 2016
ADC Therapeutics Doses First Patient in Phase I Trial of ADCT-301 in Acute Myeloid Leukemia

08 February 2016
Crescendo Biologics Presents Key Oncology Data on Humabody™ Drug Conjugates

08 February 2016
Innovations leads £5m Series A round in encapsulation specialist Aqdot

04 February 2016
Imperial Innovations: Placing to raise £100 million

03 February 2016
Premaitha Health partners with Visional Medical to provide the IONA test to pregnant women in India

02 February 2016
Premaitha Health partners with Leeds Teaching Hospitals NHS Trust to offer pregnant women safer non-invasive prenatal screening service

02 February 2016
Innovations portfolio company MISSION Therapeutics raises £60 million to progress innovative drug platform

02 February 2016
Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property

29 January 2016
Ablynx to Receive €8 Million Milestone as Boehringer Ingelheim Starts First Patient Study with a Bi-Specific Nanobody in Oncology

28 January 2016
PacificGMP makes two senior appointments

28 January 2016
Vascular Flow Technologies closes £10M financing round for strategic realignment

27 January 2016
Premaitha Health signs two new customers for its clinical laboratory NIPT screening service

26 January 2016
Polyganics Receives FDA 510(k) Clearance for Nerve Capping Device NEUROCAP

26 January 2016
Innovations genomics company Inivata completes £31.5m Series A funding round

26 January 2016
Board Change

25 January 2016
Significant licence deal for ThioBridge™ ADC linker technology signed with US biotech partner

25 January 2016
Innovations joins consortium of three world-leading UK universities and three global pharmaceutical companies to launch £40m therapeutics fund

25 January 2016
Consortium of world-leading UK universities and global pharmaceutical companies launch £40 million fund to drive therapeutic innovation

21 January 2016
Polyganics and MicroAire sign exclusive distribution agreement for peripheral nerve repair portfolio in the US, Canada and Puerto Rico

20 January 2016
AmpliPhi Biosciences Announces Dosing of First Patient in Phase 1 Clinical Trial of AB-SA01

19 January 2016
AmpliPhi Biosciences Announces Appointment of Steve R. Martin as Chief Financial Officer

19 January 2016
Half year trading update

18 January 2016
Eurostars grant awarded to international consortium including Abzena company, Antitope, for development of novel treatment for clotting disorders

18 January 2016
Innovations invests £25m in new £50m UCL Technology Fund to increase deal flow and strengthen relationship with UCL

15 January 2016
Premaitha Health welcomes recommendation for NHS provision of non-invasive prenatal testing

14 January 2016
Avita Medical Appoints Distributors in Japan and South Korea

13 January 2016
GE Healthcare, FedDev Ontario commit CAD $40M for new CCRM-led centre to solve cell therapy manufacturing challenges

13 January 2016
Avita Medical Transforms Board with Three New Appointments

11 January 2016
TROD Medical receives CE Mark Approval for Encage™

11 January 2016
Avita Medical Completes Patient Recruitment for its FDA Approval Study Evaluating Use of ReCell® in Acute Burns

08 January 2016
AmpliPhi Acquires Key Bacteriophage Assets from UK-based Novolytics

07 January 2016
Ablynx to present at the 34th Annual J.P. Morgan Healthcare Conference

06 January 2016
Adherium to Present Corporate Overview at Biotech Showcase 2016

06 January 2016
Clinical Network Services (CNS) Expands its BioDesk Service into Washington D.C.

06 January 2016
NetScientific portfolio company, Glycotest Inc., appoints world leading medical advisory board chaired by David Chernoff, M.D.

06 January 2016
Appointment of Non-Executive Chairman

05 January 2016
Premaitha Health launches Workflow Manager system for the IONA® test to support clinical laboratory customers

05 January 2016
Nanobiotix starts a new research program, in Immuno Oncology, with its lead product NBTXR3

04 January 2016
FDA approved Investigational New Drug for NBTXR3 in a new clinical study in prostate cancer